NIH-funded research R01 grant

Role of human endogenous retroviruses in type 1 diabetes progression

Official title: Dissecting the Role of Endogenous Retroviruses in Type 1 Diabetes Progression

Funded at Weill Medical Coll of Cornell Univ · NIH-11466083 · Data updated 2026-11-12

This grant studies how ancient viral elements in our DNA may boost immune activity and beta cell stress, possibly helping explain why Type 1 diabetes develops.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$831,022
NIH project number1R01DK149670-01
Project IDNIH-11466083 on NIH RePORTER

Who could benefit from this research

Could help

People with Type 1 diabetes or at high risk who may donate pancreatic tissue or share samples for research.

Less likely to help

Individuals without Type 1 diabetes or related autoimmune conditions are unlikely to directly benefit.

What this research studies

Researchers will study human pancreatic beta cells using patient-derived islets, organoid models, and humanized mice to see how hERVs influence inflammation and how beta cells present antigens to the immune system. They will examine how viral triggers and inflammatory signals activate hERVs, potentially increasing antigen presentation and T-cell activation. The goal is to map the regulatory landscape of hERV activation during Type 1 diabetes progression and connect it to beta cell vulnerability and autoimmune responses.

Why it matters

Potential benefit: Understanding hERV-driven pathways could lead to new strategies to protect beta cells and prevent or slow Type 1 diabetes.

How similar studies have gone: Preliminary studies show hERVs associate with inflammatory and antigen-presentation pathways in Type 1 diabetes, suggesting potential relevance.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Chen, Shuibing — Weill Medical Coll of Cornell Univ
  • Study coordinator: Chen, Shuibing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.